Dopaminergic drugs in the cationic form interact with D2 dopamine receptors

Trends in Pharmacological Sciences

Volumn 9, Issue 8, 1988, Pages 282-284

  Miller, Duane D ^d   Harroid, Marc ^a   Wallace, Raye Ann ^a   Wallace, Lane J ^c   Uretsky, Norman J ^b  

^a PAUSA ^*  (United States)

^b Norman Uretsky is Professor in the Department of Pharmacology at the College Of Pharmacy Pittsburgh PAUSA ^*  (United States)

^c Lane Wallace is Associate Professor in the Department of Pharmacology at the College Of Pharmacy Pittsburgh PAUSA ^*

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE DERIVATIVE; DOPAMINE 2 RECEPTOR; DOPAMINE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

DRUG RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

ANIMAL; DOPAMINE AGENTS; HUMAN; RECEPTORS, DOPAMINE; SUPPORT, NON-U.S. GOV'T;

EID: 0023786066     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-6147(88)90011-9     Document Type: Article

References (17)